دورية أكاديمية

EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34+ Cell Differentiation and Increases Circulating Endothelial Precursors.

التفاصيل البيبلوغرافية
العنوان: EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34+ Cell Differentiation and Increases Circulating Endothelial Precursors.
المؤلفون: Perrotta, Silverio, Cucciolla, Valeria, Ferraro, Marcella, Ronzoni, Luisa, Tramontano, Annunziata, Rossi, Francesca, Scudieri, Anna Chiara, Borriello, Adriana, Roberti, Domenico, Nobili, Bruno, Cappellini, Maria Domenica, Oliva, Adriana, Amendola, Giovanni, Migliaccio, Anna Rita, Mancuso, Patrizia, Martin-Padura, Ines, Bertolini, Francesco, Yoon, Donghoon, Prchal, Josef T., Ragione, Fulvio Della
المصدر: PLoS ONE; 2010, Vol. 5 Issue 8, p1-12, 12p, 1 Color Photograph, 2 Black and White Photographs, 1 Diagram, 2 Graphs
مصطلحات موضوعية: ERYTHROPOIETIN, POLYCYTHEMIA, PHOSPHORYLATION, AMINO acids, EXONS (Genetics), PROTEIN-tyrosine kinases, REGULATION of erythropoiesis, APOPTOSIS, HOMEOSTASIS
مستخلص: Background: Gain-of-function of erythropoietin receptor (EPOR) mutations represent the major cause of primary hereditary polycythemia. EPOR is also found in non-erythroid tissues, although its physiological role is still undefined. Methodology/Principal Findings: We describe a family with polycythemia due to a heterozygous mutation of the EPOR gene that causes a G→T change at nucleotide 1251 of exon 8. The novel EPOR G1251T mutation results in the replacement of a glutamate residue by a stop codon at amino acid 393. Differently from polycythemia vera, EPOR G1251T CD34+ cells proliferate and differentiate towards the erythroid phenotype in the presence of minimal amounts of EPO. Moreover, the affected individuals show a 20-fold increase of circulating endothelial precursors. The analysis of erythroid precursor membranes demonstrates a heretofore undescribed accumulation of the truncated EPOR, probably due to the absence of residues involved in the EPO-dependent receptor internalization and degradation. Mutated receptor expression in EPORnegative cells results in EPOR and Stat5 phosphorylation. Moreover, patient erythroid precursors present an increased activation of EPOR and its effectors, including Stat5 and Erk1/2 pathway. Conclusions/Significance: Our data provide an unanticipated mechanism for autosomal dominant inherited polycythemia due to a heterozygous EPOR mutation and suggest a regulatory role of EPO/EPOR pathway in human circulating endothelial precursors homeostasis. [ABSTRACT FROM AUTHOR]
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:19326203
DOI:10.1371/journal.pone.0012015